Logo

American Heart Association

  1
  0


Final ID: 12

High HDL Cholesterol Is Associated With Reduced Reperfusion Injury And Favorable Functional Outcome Following Thrombectomy For Ischemic Stroke

Abstract Body: Introduction: Animal research suggests that HDL cholesterol (HDL-C) ameliorates reperfusion injury, a phenomenon that worsens clinical outcome following recanalization therapy for ischemic stroke.
Hypothesis: We hypothesized that higher HDL-C levels have a guarding effect against cerebral reperfusion injury in human stroke survivors treated with thrombectomy.
Methods: We included patients with anterior circulation large vessel occlusion (acLVO) stroke who underwent thrombectomy from 01/2017 to 01/2023 at a tertiary stroke center in Germany into a prospective registry study with retrospective analysis. We assessed the association of HDL-C serum levels and imaging indices of post interventional reperfusion injury (any intracerebral or subarachnoid bleeding involving the ischemic brain region on CT or MRT), functional outcome quantified via modified Rankin scale (mRS) at 90 days and neurological outcome via National Institutes of Health Stroke Scale (NIHSS) score at discharge using multivariable lasso logistic and linear regression adjusted for demographic, clinical and imaging characteristics. We performed sensitivity analysis applying propensity score matching and shift analysis using ordered logistic regression.
Results: In our study population of 811 acLVO patients treated with thrombectomy (420 females, median age 77 years [66-84, interquartile range]) reperfusion injury was associated with detrimental functional outcome (adjusted OR 2.87; 95% CI [1.86;4.41]; p=0.000). Higher HDL-C was associated with lower odds of reperfusion injury (adjusted OR 0.57; 95% CI [0.35;0.95]; p=0.03) and emerged as predictor of favorable functional outcome defined as 90-day mRS 0-2 (adjusted OR 0.57; 95% CI [0.34;0.99]; p=0.04) and alleviated neurological deficits with lower NIHSS score at discharge (ß=-2.51; 95CI% [-4.88; -1.30]; p=0.04). On propensity score analysis an HDL-C level exceeding the median (1.15 mmol/L) was associated with a 13.8 % decrease in the probability of reperfusion injury (ß=-0.14; 95CI% [-0.23; -0.05]; p=0.003). A significant shift of 90-day mRS distribution favoring high HDL is shown in the figure.
Conclusions: In patients undergoing thrombectomy for acLVO a higher level of HDL-C reduced the odds of reperfusion injury, which translated into improved functional and neurological outcome, hence constituting a possible target of adjunctive neuroprotective treatment.
  • Sedghi, Annahita  ( Medical Faculty and University Hospital Carl Gustav Carus , Dresden , Germany )
  • Schreckenbauer, Sonja  ( Medical Faculty and University Hospital Carl Gustav Carus , Dresden , Germany )
  • Kaiser, Daniel  ( Medical Faculty and University Hospital Carl Gustav Carus , Dresden , Germany )
  • Cuberi, Ani  ( Medical Faculty and University Hospital Carl Gustav Carus , Dresden , Germany )
  • Arndt, Martin  ( Medical Faculty and University Hospital Carl Gustav Carus , Dresden , Germany )
  • Barlinn, Kristian  ( Medical Faculty and University Hospital Carl Gustav Carus , Dresden , Germany )
  • Puetz, Volker  ( Medical Faculty and University Hospital Carl Gustav Carus , Dresden , Germany )
  • Siepmann, Timo  ( Medical Faculty and University Hospital Carl Gustav Carus , Dresden , Germany )
  • Author Disclosures:
    Annahita Sedghi: No Answer | Sonja Schreckenbauer: DO NOT have relevant financial relationships | Daniel Kaiser: DO NOT have relevant financial relationships | Ani Cuberi: No Answer | Martin Arndt: DO NOT have relevant financial relationships | Kristian Barlinn: DO NOT have relevant financial relationships | Volker Puetz: No Answer | Timo Siepmann: DO NOT have relevant financial relationships
Meeting Info:
Session Info:

Neuroendovascular Oral Abstracts I

Wednesday, 02/05/2025 , 07:30AM - 09:00AM

Oral Abstract Session

More abstracts on this topic:
HEMERA-1: CarboxyHEMoglobin OxygEn delivery for Revascularization in Acute Stroke: A Multi-Step clinical study of safety, efficacy and Pharmacokinetics.

Linfante Italo, Clark Wayne, Haussen Diogo, Lin Eugene, Jubin Ronald, Pandya Shaunak, Liebeskind David, Nogueira Raul

A First-in-Class Humanized Antibody Fragment Targeting Platelet Glycoprotein Ibα: A Comprehensive Preclinical Study of CA1001 for the Treatment of Acute Ischemic Stroke

Xu Xiaohong, Preeti Preeti, Yu Ruoying, Shaykhalishahi Hamed, Zhang Cheng, Shen Chuanbin, Li Bei, Tang Naping, Chang Yan, Xiang Qian, Cui Yimin, Lei Xi, Ni Heyu, Zhu Guangheng, Liu Zhenze, Hu Xudong, Slavkovic Sladjana, Neves Miguel, Ma Wenjing, Xie Huifang

More abstracts from these authors:
Volume of brain saved in patients with a medium distal vessel occlusion stroke treated with endovascular therapy plus best medical treatment versus best medical treatment alone: A sub-analysis of the DISTAL Trial

Anastasiou Aikaterini, Arenillas Juan, Martínez-galdámez Mario, Hajdu Steven, Michel Patrik, Gralla Jan, Piechowiak Eike, Kaiser Daniel, Puetz Volker, Van Den Bergh Frans R.a., De Raedt Sylvie, Corbaz Helene, Bellante Flavio, Dusart Anne, Hellstern Victoria, Khanafer Ali, Parrilla Guillermo, Morales Ana, Kirschke Jan, Wunderlich Silke, Fiehler Jens, Thomalla Gotz, Brehm Alex, Lemmens Robin, Peluso Jo, Bolognese Manuel, Von Hessling Alexander, Van Es Adriaan, Kruyt Nyika, Coutinho Jonathan, Castano Carlos, Minnerup Jens, Van Zwam Wim, Müller Lioba, Dhondt Elisabeth, Nolte Christian, Machi Paolo, Loehr Christian, Mattle Heinrich, Buhk Jan-hendrik, Kaesmacher Johannes, Dobrocky Tomas, Papanagiotou Panagiotis, Alonso Angelika, Christodoulou Evangelia, Holtmannspoetter Markus, Zini Andrea, Renieri Leonardo, Keil Fee, Van Den Wijngaard Ido, Kaegi Georg, Fragata Isabel, Katan Mira, Leker Ronen, Saver Jeffrey, Ribo Marc, Staals Julie, Rommers Nikki, Balmer Luzia, Fischer Urs, Psychogios Marios, On Behalf Of The Distal Investigators ., Rizzo Federica, Strbian Daniel, Raty Silja

Impact of DOAC plasma levels on Hematoma Expansion in DOAC-associated intracerebral hemorrhage

Schoene Daniela, Tiebel Oliver, Siepmann Timo, Puetz Volker, Barlinn Kristian

You have to be authorized to contact abstract author. Please, Login
Not Available

Readers' Comments

We encourage you to enter the discussion by posting your comments and questions below.

Presenters will be notified of your post so that they can respond as appropriate.

This discussion platform is provided to foster engagement, and simulate conversation and knowledge sharing.

 

You have to be authorized to post a comment. Please, Login or Signup.


   Rate this abstract  (Maximum characters: 500)